{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Wuhan Keqian Biology Co., Ltd.
Wuhan Keqian Biology Hits Day Low at CNY 14.17 Amid Price Pressure
Wuhan Keqian Biology Co., Ltd. saw a significant decline in its stock today, reflecting broader market trends. Over the past week and month, the stock has experienced notable drops, with long-term performance showing substantial challenges. Despite this, the company maintains a market capitalization of CNY 7,565 million and a dividend yield of 2.65%.
Wuhan Keqian Biology's Valuation Upgrade Signals Stronger Market Position and Growth Potential
Wuhan Keqian Biology Co., Ltd. has recently experienced a valuation adjustment reflecting significant changes in its financial metrics. Key indicators, including a P/E ratio of 20 and a PEG ratio of 0.57, suggest a favorable market position. The company reported a profit increase of 34.2% over the past year.
Wuhan Keqian Biology Co., Ltd. Reports Mixed Financial Results Amidst Growth in Net Profit
Wuhan Keqian Biology Co., Ltd. reported its financial results for the quarter ending March 2025, highlighting a significant net profit growth of 68.05% year-over-year. The company also saw a decrease in raw material costs and demonstrated strong operational efficiency, indicating potential for improved financial health moving forward.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
